Kheir, Alaa, Berglind Johannsdottir, Alexandra Grönn-Weiss, Lisa L Liu, Anders Ullén, Anna Laurell, Annika Håkansson, et al. “Baseline Laboratory Values and Metastatic Burden Predict Survival in Addition to IMDC Risk in Real-World Renal Cell Carcinoma Patients Treated With Ipilimumab-Nivolumab”. Acta Oncologica 64 (October 3, 2025): 1355–1364. Accessed June 1, 2026. https://medicaljournalssweden.se/actaoncologica/article/view/44533.